Trial intelligence / Profile preview

Compound levonorgestrel tablet for contraception

CTR20130085Phase 3Terminated

Sponsor
Guangzhou Langsheng Pharmaceutical
Start
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ethinylestradiol + levonorgestrel in contraception, sponsored by Guangzhou Langsheng Pharmaceutical. Started Jan 2015; status: terminated.

02

Drugs

ethinylestradiol + levonorgestrel
03

Conditions

contraception

Beyond the preview

Go deeper on CTR20130085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call